Health & Medicine
Manchester’s ‘first step’ to perfect drug combinations
24 Oct 2011
Scientists at The University of Manchester have discovered a way of speeding up the creation of perfect drug combinations, which could help patients recovering from critical health problems such as stroke, heart attacks and cancer.
Virtual reality helps treat social anxiety
24 Oct 2011
Early origins of chronic mid-life diseases: Low birth weight and poverty have long-term effects
22 Oct 2011
Genetically influenced responses to alcohol affect brain activation
By By Debra Kain | 19 Oct 2011
Antiviral drugs may slow Alzheimer’s progression
18 Oct 2011
Antiviral drugs used to target the herpes virus could be effective at slowing the progression of Alzheimer’s disease (AD), shows a new study
Sniffing out the brain's predictive power
15 Oct 2011
Researchers find that the brain smells what it expects rather than what it sniffs
Monitoring how T cells respond to HIV
By Anne Trafton, MIT News Office | 15 Oct 2011
One of the obstacles to developing an effective AIDS vaccine is the difficulty in measuring how well a potential vaccine primes the body to defend itself against HIV.
Inhaler treatment for lung cancer
12 Oct 2011
Safer and more efficient lung cancer treatment through a nebuliser may replace current intravenous delivery
Study identifies earliest stages of Alzheimer's
12 Oct 2011
Light can detect pre-cancerous colon cells
By By Richard Merritt | 11 Oct 2011
This technology could be a non-invasive way for physicians to detect abnormal cells, or dysplasia, which have the potential of turning cancerous
Immune mechanism blocks inflammation generated by oxidative stress
By By Scott LaFee | 07 Oct 2011
Latest articles
Featured articles
The decoupling paradox: Why Wall Street keeps funding AI despite $100 oil
By Axel Miller | 11 May 2026
AI infrastructure stocks continue rallying despite $100 oil as investors bet on productivity gains and semiconductor demand in 2026.
Hybrid bonding gains attention as AI chip packaging demand grows
By Cygnus | 23 Apr 2026
Hybrid bonding is driving AI chip packaging demand as backend technologies gain importance in the semiconductor supply chain.
The agentic transition: how enterprises are scaling AI from pilot to profit
By Cygnus | 22 Apr 2026
AI has entered its execution era. Discover how companies like Valeo and Microsoft are scaling agentic AI systems—from copilots to autonomous workflows driving real business impact.
Post-splashdown: What Artemis II taught us about the ‘deep space wall’
By Axel Miller | 15 Apr 2026
Artemis II splashdown marks a breakthrough in deep space exploration. Discover AVATAR radiation data, Orion’s distance record, and insights shaping NASA’s 2028 Moon mission.
Can aviation go green? The multi-billion dollar race for sustainable fuel
By Cygnus | 10 Apr 2026
Airlines are racing to adopt sustainable aviation fuel, but limited supply and high costs challenge the future of green aviation.
The battery race: who will control the future of electric vehicles?
By Axel Miller | 08 Apr 2026
The global battery race is reshaping the electric vehicle industry, with China, the US, and Europe competing for control over supply chains and technology.
AI vs governments: Who controls the future of intelligence?
By Cygnus | 07 Apr 2026
Governments and AI companies like OpenAI and Anthropic are shaping the future of intelligence amid rising policy conflicts and global competition.
Strait of Hormuz: how one chokepoint controls the global economy
By Axel Miller | 06 Apr 2026
The Strait of Hormuz is a critical global chokepoint. Learn how disruptions impact oil prices, shipping, and the global economy.
The $2 trillion AI infrastructure race: Who will control global compute?
By Cygnus | 06 Apr 2026
AI spending is set to exceed $2 trillion in 2026, driving a global race in data centers, chips, and energy infrastructure.
